First safety test for new antibiotic in kidney patients
NCT ID NCT07104162
Summary
This early-stage study is testing a new combination antibiotic in people with different levels of kidney function. Researchers will give a single dose to 40 participants, including those on dialysis, to see how their bodies process the drug and check for side effects. The goal is to gather information to help determine safe future doses for patients with kidney disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
Contact
Contact
-
University of Miami Clinical Pharmacology
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.